Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-26

Clinical Trial Update: Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Endostar in combination with chemotherapy for stage IV soft tissue sarcoma has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Endostar (recombinant human endostatin)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Soft Tissue Sarcoma, Adult, Stage IIB | Phase 2 | Status: COMPLETED